Published in Gene Therapy Weekly, April 20th, 2006
According to a study from Japan, "ATRA has been shown to exert anticancer activities in a number of types of cancer cells. However, it has been reported that many NSCLC exhibited resistance to ATRA treatment."
"In the present study, we hypothesized that intracellular delivery of ATRA would overcome the ATRA resistance in A549 cells," explained S. Kawakami and colleagues, Kyoto University. "Here, we investigated the induction of apoptosis by ATRA incorporated in cationic liposomes composed of DOTAP/cholesterol in A549 human lung cancer cells, which are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.